Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients.

Lukic R, Gajovic N, Jovanovic I, Jurisevic M, Mijailovic Z, Maric V, Popovska Jovicic B, Arsenijevic N.

Dis Markers. 2017;2017:6275987. doi: 10.1155/2017/6275987. Epub 2017 Apr 11.

2.

Protocol of randomized control trial for effectiveness of angiotensin receptor blockers on blood pressure control among euvolemic hypertensive hemodialysis patients.

Aftab RA, Khan AH, Syed Sulaiman SA, Khan TM, Adnan AS.

Medicine (Baltimore). 2017 Apr;96(14):e6198. doi: 10.1097/MD.0000000000006198.

3.

Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosis.

Drummond CA, Brewster PS, He W, Ren K, Xie Y, Tuttle KR, Haller ST, Jamerson K, Dworkin LD, Cutlip DE, Murphy TP, D'Agostino RB Sr, Henrich WL, Tian J, Shapiro JI, Cooper CJ.

PLoS One. 2017 Mar 17;12(3):e0173562. doi: 10.1371/journal.pone.0173562. eCollection 2017.

4.

Association between macular degeneration and mild to moderate chronic kidney disease: A nationwide population-based study.

Chen CY, Dai CS, Lee CC, Shyu YC, Huang TS, Yeung L, Sun CC, Yang HY, Wu IW.

Medicine (Baltimore). 2017 Mar;96(11):e6405. doi: 10.1097/MD.0000000000006405.

5.

Blood pressure and age-related GFR decline in the general population.

Eriksen BO, Stefansson VT, Jenssen TG, Mathisen UD, Schei J, Solbu MD, Wilsgaard T, Melsom T.

BMC Nephrol. 2017 Feb 28;18(1):77. doi: 10.1186/s12882-017-0496-7.

6.

Long-term renal outcomes in patients with traumatic brain injury: A nationwide population-based cohort study.

Wu CL, Kor CT, Chiu PF, Tsai CC, Lian IB, Yang TH, Tarng DC, Chang CC.

PLoS One. 2017 Feb 14;12(2):e0171999. doi: 10.1371/journal.pone.0171999. eCollection 2017.

7.

Increased Serum Sodium and Serum Osmolarity Are Independent Risk Factors for Developing Chronic Kidney Disease; 5 Year Cohort Study.

Kuwabara M, Hisatome I, Roncal-Jimenez CA, Niwa K, Andres-Hernando A, Jensen T, Bjornstad P, Milagres T, Cicerchi C, Song Z, Garcia G, Sánchez-Lozada LG, Ohno M, Lanaspa MA, Johnson RJ.

PLoS One. 2017 Jan 12;12(1):e0169137. doi: 10.1371/journal.pone.0169137. eCollection 2017.

8.

Ideal cardiovascular health score and incident end-stage renal disease in a community-based longitudinal cohort study: the Kailuan Study.

Han QL, Wu SL, Liu XX, An SS, Wu YT, Gao JS, Chen SH, Liu XK, Zhang Q, Mao RY, Shang XM, Jonas JB.

BMJ Open. 2016 Nov 29;6(11):e012486. doi: 10.1136/bmjopen-2016-012486.

9.
10.

Chronic kidney disease: identification and management in primary care.

Fraser SD, Blakeman T.

Pragmat Obs Res. 2016 Aug 17;7:21-32. eCollection 2016. Review.

11.

An Analysis of Anthropometric Indicators and Modifiable Lifestyle Parameters Associated with Hypertensive Nephropathy.

Aryee C, Owiredu WK, Osei-Yeboah J, Owusu-Dabo E, Laing EF, Owusu IK.

Int J Hypertens. 2016;2016:6598921. Epub 2016 Sep 27.

12.

Patients with urothelial carcinoma have poor renal outcome regardless of whether they receive nephrouretectomy.

Hung PH, Tsai HB, Hung KY, Muo CH, Chung MC, Chang CH, Chung CJ.

Oncotarget. 2016 Sep 20;7(38):61679-61689. doi: 10.18632/oncotarget.11223.

13.

A Study of Reverse Causation: Examining the Associations of Perfluorooctanoic Acid Serum Levels with Two Outcomes.

Dhingra R, Winquist A, Darrow LA, Klein M, Steenland K.

Environ Health Perspect. 2017 Mar;125(3):416-421. doi: 10.1289/EHP273. Epub 2016 Aug 16.

14.

Simple obstructive sleep apnea patients without hypertension or diabetes accelerate kidney dysfunction: a population follow-up cohort study from Taiwan.

Lin YS, Liu PH, Lin SW, Chuang LP, Ho WJ, Chou YT, Juan KC, Lo MT, Chu PH, Chen NH.

Sleep Breath. 2017 Mar;21(1):85-91. doi: 10.1007/s11325-016-1376-2. Epub 2016 Jul 5.

15.

Interleukin-6 inhibition attenuates hypertension and associated renal damage in Dahl salt-sensitive rats.

Hashmat S, Rudemiller N, Lund H, Abais-Battad JM, Van Why S, Mattson DL.

Am J Physiol Renal Physiol. 2016 Sep 1;311(3):F555-61. doi: 10.1152/ajprenal.00594.2015. Epub 2016 Jun 8.

PMID:
27279492
16.

Cigarette Smoking and Chronic Kidney Disease in African Americans in the Jackson Heart Study.

Hall ME, Wang W, Okhomina V, Agarwal M, Hall JE, Dreisbach AW, Juncos LA, Winniford MD, Payne TJ, Robertson RM, Bhatnagar A, Young BA.

J Am Heart Assoc. 2016 May 25;5(6). pii: e003280. doi: 10.1161/JAHA.116.003280.

17.

Proteinuria as a Therapeutic Target in Advanced Chronic Kidney Disease: a Retrospective Multicenter Cohort Study.

Chen CH, Wu HY, Wang CL, Yang FJ, Wu PC, Hung SC, Kan WC, Yang CW, Chiang CK, Huang JW, Hung KY.

Sci Rep. 2016 May 20;6:26539. doi: 10.1038/srep26539.

18.

Podocytes: the Weakest Link in Diabetic Kidney Disease?

Lin JS, Susztak K.

Curr Diab Rep. 2016 May;16(5):45. doi: 10.1007/s11892-016-0735-5. Review.

19.

Risk Factors for Development of Chronic Kidney Disease in Cats.

Finch NC, Syme HM, Elliott J.

J Vet Intern Med. 2016 Mar-Apr;30(2):602-10. doi: 10.1111/jvim.13917. Epub 2016 Mar 6.

20.

Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide.

Cernaro V, Santoro D, Lacquaniti A, Costantino G, Visconti L, Buemi A, Buemi M.

Int J Nephrol Renovasc Dis. 2016 Feb 2;9:11-9. doi: 10.2147/IJNRD.S78040. eCollection 2016. Review.

Supplemental Content

Support Center